Amino acid dialysis fluid for diabetic patients on PD
Part of Hormones & metabolism clinical trials.
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old with type 1 or type 2 diabetes.
- You have been on peritoneal dialysis for at least 3 months and use 3–5 bags of dialysis fluid daily.
- Your HbA1c (average blood sugar) is between 6.0% and 8.5%.
- Your hemoglobin level is between 90 and 130 g/L (normal range for dialysis patients).
- You haven't had peritonitis (abdominal infection) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
This trial tests a special dialysis fluid with amino acids (building blocks of protein) to see if it helps improve nutrition in people on peritoneal dialysis who have low protein levels. If you qualify, it may help boost your nutrition.
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
This Phase 3 trial studies how well a new peritoneal dialysis solution works and whether it is safe. It’s meant for adults with kidney failure who already do a specific type of at-home dialysis.
This study tests whether giving amino acids directly into the blood during dialysis can reduce stiffness in blood vessels, which is common in kidney failure and can lead to heart problems. If you are on stable dialysis, this treatment might help improve your vascular health.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.